Adial Pharmaceuticals, Inc.
ADIL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001513525
In the last 90 days, Adial Pharmaceuticals, Inc. insiders filed 2 open-market purchases and 0 sales; 17 institutions reported holding it in 13F filings for Q2 2026, worth $334.6K in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Adial Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 20 | 19 | −1 |
| Shares | 806.7K | 1.23M | +427.6K (+53.0%) |
| Value | $1.95M | $3.15M | +$1.19M (+61.2%) |
New holders (4)
Institutions that held Adial Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| State Street Corp | 48,954 | $125.0K | 0.00% |
| Virtu Financial LLC | 31,038 | $79.0K | 0.01% |
| Golden Green, Inc. | 24,700 | $63.0K | 0.05% |
| Northern Trust Corp | 21,873 | $56.0K | 0.00% |
Sold out (5)
Institutions that held Adial Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Barclays PLC | 15,850 | $38.0K |
| Creative Planning | 10,000 | $24.0K |
| UBS Group AG | 4,447 | $11.0K |
| Wealthcare Capital Management LLC | 375 | $1.00K |
| FMR LLC | 125 | $0 |